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Thestateofpneumococcalcarriage—thatis,pneumococcalcolonizationinthenasopharynxofhealthypersons—
represents a reservoir for the spread of pneumococci among individuals. In light of the introduction of new
pneumococcal conjugate vaccines, further knowledge on the dynamics of pneumococcal carriage is important.
Different serotypes (strains) of pneumococcus are known to compete with each other in colonizing human hosts.
Understanding the strength and mode of between-serotype competition is important because of its implications for
vaccine-induced changes in the ecology of pneumococcal carriage. Competition may work through reduced
acquisition of new serotypes, due to concurrent carriage in the individual, or through enhanced clearance of
serotypes in carriers who harbor more than 1 serotype simultaneously. The authors employed longitudinal data
(1999–2001)onpneumococcalcarriageinDanishday-carechildrentoanalyzebetween-serotypecompetition.The
dataincludedobservationsofcarriageinchildrenwhohadnotbeenvaccinatedagainstpneumococcus,andthelevel
of pneumococcal antibiotic resistance and antibiotic usage in the community was very low. Clearance of any single
serotype was not affected by simultaneous carriage of other serotypes. In contrast, acquisition of other serotypes in
already-colonized hosts was weak (relative rate of acquisition ¼ 0.09, 95% credible interval: 0.05, 0.15).
child; day care; disease reservoirs; longitudinal studies; models, statistical; Streptococcus pneumoniae
Abbreviations: CI, credible interval; DCC, day-care center.
Streptococcus pneumoniae (pneumococcus) has91 known
serotypes (1). Many serotypes are commonly found in naso-
pharyngeal carriage, particularly among young children,
who form the main reservoir of pneumococci and their trans-
mission to new hosts (2–4). Although pneumococcal car-
riage is mostly transient and asymptomatic, it is also a
prerequisite to pneumococcal disease (e.g., middle-ear in-
fection, pneumonia, meningitis) (5). The pneumococcal con-
jugate vaccine is efﬁcacious in preventing serious forms of
pneumococcal disease caused by serotypes included in the
vaccine (6–9). At the same time, its use reduces acquisition
of vaccine-type pneumococcal carriage, thus inducing indi-
rect protection against carriage and disease in the unvacci-
natedaswellaspotential forreplacementofvaccinetypesby
nonvaccine types as causes of carriage and disease (10–13).
Epidemiologic data suggest that different serotypes
(strains) of S. pneumoniae compete with each other in col-
onizing human hosts. In the United States, vaccine-type
carriage has been replaced by non-vaccine-type carriage
during large-scale use of the pneumococcal conjugate vac-
cine since 2000 (11, 14–16). Such replacement implies the
existence of between-strain competition that has opened
a niche for nonvaccine types under the reduced carriage of
vaccine-type pneumococci (17). Analyses of follow-up data
about pneumococcal carriage have revealed interactions be-
tween acquisition of speciﬁc serotypes and the current status
of carriage in the individual (18). Understanding the mode
and strength of between-strain competition is important for
interpreting past trends and predicting potential changes in
the ecology of pneumococcus under vaccination pressure.
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have been investigated by means of theoretical modeling
(17, 19). Competition may work through reduced acquisi-
tion of new serotypes, due to current (resident) carriage of
other serotypes in the individual. Alternatively, clearance of
pneumococcus may be enhanced in carriers who harbor
more than 1 serotype simultaneously. Another type of in-
teraction between pneumococcal serotypes may work
through acquired immunity to subsequent acquisition, in-
duced by encounters with speciﬁc serotypes (20) or pneu-
mococci in general. Although it is possible to investigate
some of these mechanisms experimentally in mouse models,
it is important to reveal patterns of competition using epi-
demiologic data on humans.
Epidemiologic data may suffer from limitations of the
method used to identify pneumococcal carriage. First, pneu-
mococcal carriage has an episodic nature and can usually
only be detected by active sampling. The sampling fre-
quency may bias analysis of pneumococcal episodes from
longitudinal data. Second, inferences about pneumococcal
carriage may be affected by the nonoptimal sensitivity of
pneumococcus detection (21). The standard procedure of
randomly picking only 1 or 2 colonies suspected to be pneu-
mococci for identiﬁcation and typing from a plate of a naso-
pharyngeal specimen often yields only 1 serotype per
sampling. However, double or multiple carriage occurs, with
ratesthatmaydifferacrossdifferentpopulationsandmethods
of detection (22–26). For analyses of between-serotype com-
petition, it is particularly important that pneumococcal car-
riage and multiple carriage be identiﬁed systematically with
high sensitivity.
We employed longitudinal data on pneumococcal car-
riage in children to analyze competition between pneumo-
coccal serotypes in colonizing human hosts. Detection of
pneumococcal serotypes was based on a new method that
allows more sensitive observation of simultaneous carriage
of pneumococci than the standard method (27). We used the
data to assess the effect of current carriage on acquisition of
other serotypes and to assess the effect of co-colonizing
serotypes on clearance in multiple carriers.
MATERIALS AND METHODS
Study participants
Childrenattending3day-carecenters(DCCs)inRoskilde,
Denmark, and employees of the DCCs were considered for
enrollment in an open cohort study of pneumococcal car-
riage. The DCCs were nurseries for children under 3 years
of age. Altogether, 123 DCC attendees (49 in DCC 1, 40 in
DCC2,and34inDCC3)and37DCCemployees(14,12,and
11, respectively) were enrolled as study participants. The
median age of children at enrollment was 1.9 years (range,
0.9–3.2). None of the participants had been immunized with
a pneumococcal vaccine.
Written informed consent was obtained from the parents
of each child and from the adult participants. The local
ethical committee and the Department on Children and Cul-
ture in Roskilde Municipality approved the study (27).
Samples
Children in DCCs 1 and 2 were followed from April 1999
to February 2001, and children in DCC 3 were followed
from December 1999 to February 2001 (see Web Figure
1, which is posted on the Journal’s Web site (http://aje.
oxfordjournals.org/)). Deep nasopharyngeal samples were
collected with a calcium alginate swab from the study par-
ticipants at monthly visits to the DCCs. The ﬁrst 2 sampling
rounds in DCCs 1 and 2 were omitted from the present anal-
ysis because of infrequent sampling (>45 days between con-
secutive samples). Thus, there were 15 sampling rounds
i n c l u d e df r o mb o t hD C C1a n dD C C2a n d1 2f r o mD C C3 ,
involving 104 children altogether. The median numbers of
children under observation were 15, 13, and 17, respectively—
approximately 50% of children in each DCC. Except for 1
instance, all samples taken during a particular sampling
round (visit) in a DCC were collected within 8 days. Chil-
dren left the study cohort because of age (63 children; me-
dian age at exit, 2.8 years) or the end of the study (41
children; median age at exit, 2.2 years).
Altogether, 571 samples were taken from the 104 chil-
dren. The average stay per child in the DCC was 0.5 years,
and the median number of samples per child was 5 (range,
1–15). The 161 samples taken from the 37 employees (me-
dian age, 44 years) were used only to deﬁne serotype-
speciﬁc exposure in children (see below).
Serum broth, made from beef infusion and enriched with
5% horse serum and 0.33% deﬁbrinated horse blood, was
used as a transport and enrichment culture medium. The
inoculated broth was incubated overnight in air with extra
5% carbon dioxide at 35 C, and the presence of 1 or more of
the 91 pneumococcus serotypes was then determined di-
rectly in the broth cultures by means of the capsular reaction
test, using a panel of pneumococcal group- and type-speciﬁc
antisera (27). In the analysis, serotypes 15B and 15C were
considered 1 type (15B/C) because of reversible serotype
switching between them (28).
Deﬁnitions and statistical methods
The individual follow-up period was deﬁned as the time
from the ﬁrst sample taken in the child to the last sample. If
there were more than 45 days between the collection of any
2 consecutive samples, follow-up was discontinued for the
time interval between the 2 samples. For each child, serotype-
speciﬁc episodes of carriage were deﬁned for the 8 most com-
monserotypes in this study (6B, 6A, 23F,19F,14, 19A, 15B/
C, 11A) as series of isolations of the same serotype at con-
secutive visits. For the crude analysis, each episode was
assumed to start midway between the ﬁrst isolation of the
type (serotype or ‘‘noncarriage’’) in the episode and the
previous visit and correspondingly to end midway between
the last isolation in the episode and the following visit. The
remaining 109 isolates (23% of isolates, representing 21
serotypes and 16 nontypable isolates) were treated as a sin-
gle group, and episodes for this group of deidentiﬁed types
were determined subsequently. For convenience, in the 5
instances of 3 simultaneous serotypes in a sample, the rarest
of the 3 isolates was omitted in the subsequent analyses.
170 Auranen et al.
Am J Epidemiol 2010;171:169–176Samples that had been collected more than 45 days from any
other samples inthe individualwerediscardedinthe episode-
based analyses. These 67 samples were not different from
the included samples with respect to age at sampling, prev-
alence of carriage, or number of siblings (data not shown).
Episodes of carriage were split as being either ‘‘single
carriage’’ (only 1 serotype) or ‘‘double carriage’’ (2 simul-
taneous serotypes) (see Figure 1). To study whether current
carriage affected pneumococcus acquisition, we estimated
acquisition rates separately for noncarriers (e.g., rate a; see
Figure 1) and carriers (rate ha a). Likewise, to study whether
pneumococcus clearance was affected by the presence of
another serotype, we estimated clearance rates separately
for single (e.g., rate la) and double (rate uala) carriers.
The 8 target serotypes were taken to share a common rate
of acquisition and a common rate of clearance, but each
episode was identiﬁed individually. The deidentiﬁed group
had its own rate parameters. The interval-censored times of
onset and clearance of carriage were taken into account in
the statistical analysis (see the Web Appendix, which is
posted on the Journal’s Web site (http://aje.oxfordjournals.
org/)).
The observed data included transitions that bypass an in-
termediate epidemiologic state in Figure 1. There were 72
instances in which a participant was observed to ﬁrst carry
a speciﬁc serotype at one visit and then another serotype at
a visit made 1 month later. In addition, in 3 instances, a par-
ticipant was observed to be a noncarrier at onevisit and then
a double carrier at the next visit; and in 5 instances, a par-
ticipant was observed to be a double carrier at one visit and
then a noncarrier at the next visit. In the crude analysis, the
unknown intermediate states were imputed for convenience.
In the actual analysis using statistical modeling, such in-
termediate states were treated as unknown variables (see
Web Appendix). The 6 instances in which more than 2
transitions would have been required were omitted from
these analyses.
Serotype-speciﬁc exposure to pneumococci was deﬁned
as carriage (yes/no) of the target type by at least 1 other
person, including employees, in the DCC during the child’s
episode (see Web Appendix). The effect of this binary co-
variate was assumed to be the same for all target serotypes.
Results from the statistical model are given as Bayesian
posterior mean estimates of the parameters and their 95%
credible intervals.
RESULTS
Carriage of pneumococci and the serotype distribution
In the children, 74.1% (423/571) of samples were positive
for pneumococci. The proportion of carriers was 80% in
samples taken from children under 2 years of age, as com-
pared with 70% in the older children. The prevalence of
pneumococcal carriagewas relatively high in the employees
(21.7%; 35/161). Carriage with multiple pneumococcal se-
rotypes was common among children: 10.9% of positive
samples (46/423) contained more than 1 serotype (25/186
in children aged <2 years and 21/237 in older children),
with 41 and 5 instances of 2 and 3 simultaneous serotypes,
respectively. In the employees, the proportion of carriers of
multiple serotypes was likewise high, as 20% of positive
samples contained more than 1 serotype.
Table 1 shows the serotype distribution among the 474
isolates in the children. The usual pediatric serotypes dom-
inated, with the 8 most common serotypes accounting for
77% of the isolates. The serotypes observed in the em-
ployees were similar to those in the children, except for
serotype 20, which was found disproportionately in the em-
ployees (9 of the 19 isolates of serotype 20 in the data).
The serotype distribution among the 298 episodes of car-
riage in children was similar to that in the isolates (Table 1).
The serotypes in double carriers reﬂected those in single
carriers (data not shown). Splitting the follow-up time ac-
cording to carriage’s being ‘‘single’’ or ‘‘double’’resulted in
252 episodes of single carriage and 28 episodes of double
carriage. The total person-time for double carriage was 25
person-months, approximately 10% of the total person-time
spent carrying pneumococci. There were 167 episodes of
noncarriage.
Crude analysis
Table 2 presents the crude rates of pneumococcus acqui-
sition (any serotype) in the children, calculated from num-
bers of acquisitions per person-time, stratiﬁed according to
current carriage status (‘‘noncarriage’’ vs. ‘‘single car-
riage’’). The crude rate of pneumococcus acquisition was
1.022 per month in a noncarrying child but only 0.085 per
month in a carrying child. This difference suggests strongly
reduced acquisition of other serotypes in already-colonized
Figure 1. Epidemiologic ‘‘states’’ (compartments) and ‘‘transitions’’
for acquisition and clearance of 2 Streptococcus pneumoniae sero-
types, A and B. State ‘‘0’’ denotes noncarriage, and state ‘‘AB’’ de-
notes simultaneous carriage of types A and B. The actual analysis
accommodated the corresponding states: ‘‘noncarriage,’’ ‘‘single car-
riage’’ for each of the 8 serotypes and the deidentiﬁed group (9 states
altogether), and ‘‘double carriage’’ for all pairwise combinations of
states of single carriage (9 3 8/2 ¼ 36 states). For more details,
see the Web Appendix (http://aje.oxfordjournals.org/).
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were at least 1 magnitude smaller than the overall rate of
acquisition (Table 2). The numbers of acquisitions were
small, excluding the possibility of addressing possible dif-
ferences across serotypes.
Table 3 presents the crude rates of clearance in the chil-
dren, calculated from numbers of clearances per person-
time, stratiﬁed according to carriage’s being ‘‘single’’ or
‘‘double.’’ If the rate of clearance of individual serotypes
is faster in double carriers than in single carriers, the rate of
clearance of double carriage (to single carriage of either of
the 2 types) should be more than 2-fold that in single car-
riers. However, the crude estimate of this ratio was only 1.5
(0.94 vs. 0.65), suggesting that such enhancement of clear-
ance does not occur in double carriers.
Adjusted analysis
Table 4 summarizes results from the statistical model.
The posterior mean rate of acquisition for a target serotype
in a noncarrying child was 0.06 per month (95% credible
interval (CI): 0.04, 0.09). This rate appears smaller than
could be inferred from the crude analysis (Table 1). How-
ever, unlike the crude rate, the adjusted rate represents that
in the absence of exposure to the type in question within the
DCC. For the deidentiﬁed group, the rate of acquisition was
higher (0.24 per month) than for an individual target sero-
type, describing the total rate of the 21 minor serotypes in
the data. This rate is very similar to that from the crude
analysis (neither analysis adjusted for exposure to this non-
speciﬁc ‘‘type’’). Based on the results in Table 4, the overall
rate of pneumococcus acquisition in a noncarrying child was
approximately 0.7 per month (i.e., 8 3 0.06 þ 0.24).
The current status of carriage affected pneumococcus ac-
quisition. The relative rate of acquisition (carrying vs. non-
carrying children) was 0.09 (95% CI: 0.05, 0.15). For the
deidentiﬁed group, the relative rate was similar (relative
rate ¼ 0.11, 95% CI: 0.02, 0.31). These results, of an approx-
imately 10-fold higher rate of acquisition in noncarriers, are
parallel to those from the crude analysis and indicate strong
competition among serotypes to colonize hosts.
In addition to current status of carriage in the child, the
rate of acquisition was clearly affected by exposure to pneu-
mococci within the DCC. The relative rate of acquisition for
a target type was 2.7 (95% CI: 1.7, 4.4) when a child was
exposed to that type within the DCC, as compared with the
case where there was no exposure to the target type.
For a target serotype, the rate of clearance was 0.63 per
month (95% CI: 0.51, 0.79). The relative rate of clearance
(double carrier vs. single carrier) was 0.81 (95% CI: 0.48,
1.26). For the deidentiﬁed group, the rate of clearance was
0.63 (95% CI: 0.41, 0.90), and the relative rate of clearance
(double carriers vs. single carriers) was 0.80 (95% CI: 0.22,
2.17). The ﬁndings of similar clearance rates in single and
double carriers again agree with those of the crude analysis,
suggesting that the presence of another serotype does not
affect clearance of other colonizing serotypes.
Finally, the model was used to assess the likely course of
transitions in the instances of unknown intermediate states.
For observed transitions from carriage of one type (e.g., A;
see Figure 1) to carriage of another type (B), approximately
90% were estimated to have taken place through the state of
‘‘noncarriage.’’ This result reﬂects the estimated strong in-
hibition of current carriage against acquisition of other se-
rotypes. Transitions from noncarriage to double carriage
(target types A and B) were estimated to take place half
of the time through carriage of type A, as a consequence
of the assumed similarity of all target serotypes.
DISCUSSION
We employed longitudinal data on pneumococcal car-
riage in children to study interactions between co-colonizing
serotypes. Detection of pneumococcal carriage was based
on a new method that allows more sensitive measurement
of carriage of multiple pneumococcal populations in the
same nasopharyngeal sample than the standard method.
We found that children simultaneously carrying 2 different
serotypes cleared carriage of either of the serotypes at the
same rate as children carrying only 1 serotype. In contrast,
acquisition of another serotype was 10 times slower in chil-
dren who already carried 1 serotype. These epidemiologic
ﬁndings imply that between-strain competition among
pneumococci works primarily through acquisition, current
Table 1. Distribution of Streptococcus pneumoniae Serotypes
Among Children and Employees at 3 Day-Care Centers in Denmark,
1999–2001
Serotype
Isolates Episodes
a
(Among
Children) Children Employees Total
No. % No. % No. % No. %
23F 92 19.4 5 11.4 97 18.7 51 17.1
19F 86 18.1 2 4.5 88 17.0 54 18.1
6B 53 11.2 3 6.8 56 10.8 26 8.7
6A 45 9.5 3 6.8 48 9.3 34 11.4
19A 27 5.7 3 6.8 30 5.8 13 4.4
14 22 4.6 1 2.3 23 4.4 17 5.7
15B/C 21 4.4 5 11.4 26 5.0 14 4.7
11A 19 4.0 0 0.0 19 3.7 14 4.7
22F 18 3.8 0 0.0 18 3.5 12 4.0
33F 12 2.5 1 2.3 13 2.5 9 3.0
9V 10 2.1 1 2.3 11 2.1 5 1.7
20 10 2.1 9 20.5 19 3.7 10 3.4
Nontypable
isolates
14 3.0 7 15.9 21 4.1 32 10.7
Other
serotypes
b 45 9.5 4 9.1 49 9.5 7 2.3
Total 474 100 44 100 518 100 298 100
a An episode of pneumococcal carriage was deﬁned as a series of
isolations of a homologous (same) serotype at consecutive visits.
b Serotypes in the children (total numbers of isolates): 10A (8), 18C
(8), 35F (7), 3 (5), 4 (4), 16F (2), 17F (2), 18B (2), 21 (2), 35B (2), 37
(2), 7B (2), 23A (1), 31 (1), 38 (1), 7F (1), 9N (1). Serotypes in the
employees (total numbers of isolates): 35F (2), 21 (1), 37 (1).
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coccal strains.
The data were derived from children attending 3 DCCs in
Denmark, a country with low levels of antibiotic resistance
in invasive pneumococcal disease, associated with an inter-
nationally low level of antibiotic usage in all age groups
(29). The 7-valent pneumococcal conjugate vaccine was in-
troduced in the Danish childhood vaccination program in
October 2007. The current study thus represented a unique
opportunity to study the natural dynamics of pneumococcal
carriage among children in day-care settings, without the
inﬂuence of pneumococcal vaccination and with low usage
of antimicrobial agents.
The data included a number of consecutive pairs of ob-
servations within an individual that bypassed an intermedi-
ate epidemiologic state in the model shown in Figure 1.
Most notably, there were 72 pairs of consecutive samples
taken fewer than 45 days apart, where a participant was ﬁrst
observedto carry one serotype and subsequentlyobservedto
carry another. In the crude analysis of acquisition (Table 2),
all such transitions from carriage of one type to carriage of
another were assumed to have occurred through an interme-
diate state of ‘‘noncarriage.’’ In this analysis, the ratio of the
crude rates of acquisition (double vs. single carriage) was
approximately 0.1. However, had all these transitions taken
place through double carriage, the ratio would have been
approximately 0.7.
To address the problem of missing data, we employed
a statistical model to probabilistically impute unknown in-
termediate states. For example, in each of the 72 instances,
the intermediate state was assigned statistically as either
‘‘noncarriage’’ or ‘‘double carriage.’’ The results of this
analysis clearly suggest that a great majority (90%) of tran-
sitions from carriage of one serotype to carriage of another
indeed occur as a sequence of events, where single carriage
is ﬁrst cleared and the other type is then acquired. In terms
of model parameters, this is reﬂected in the strong inhibition
provided by current carriage against acquisition of another
type, with a relative rate of only 9% of that in noncarriers
(Table 4).
It is important for analyses of between-strain competition
that pneumococcal carriage be identiﬁed with sufﬁciently
high sensitivity. Two aspects must be considered here. First,
the analysis in this paper was based on episodes of car-
riage that were determined from repeated (monthly) within-
individual measurements. It is then possible that short periods
of carriage remained completely unobserved or were artiﬁ-
cially lengthened when episodes of carriage were created,
causing problems for the analysis of episodes of double car-
riage in particular. Second, the laboratory sensitivity to ob-
serve populations of different pneumococcal serotypes may
hinder the analysis of multiple carriage.
Even if the true episodes of double carriage were shorter
than those of single carriage, episodes based on sampling
that is too infrequent could appear similar in length. This
would result in a false conjecture on reduced acquisition
(because of completely missing episodes) and clearance
(because our episode deﬁnitionwouldcreate artiﬁciallylong
Table 2. Acquisition of Streptococcus pneumoniae Carriage (Crude Analysis) Among Children at 3 Day-Care Centers in Denmark, 1999–2001
Target
Serotype
Episodes of Noncarriage Episodes of the Nontarget Type (Single Carriers)
No. of
Episodes
Person-Time
at Risk,
months
a
No. of
Acquisitions
b
Rate
(Acquisitions
per Month)
No. of
Episodes
Person-Time
at Risk,
months
c
No. of
Acquisitions
d
Rate
(Acquisitions
per Month)
6B 167 126.28 20 0.158 220 170.12 2 0.012
6A 167 126.28 8 0.063 228 179.60 2 0.011
23F 167 126.28 26 0.206 206 159.65 1 0.006
19F 167 126.28 22 0.174 207 167.05 6 0.036
14 167 126.28 10 0.079 239 187.00 1 0.005
19A 167 126.28 5 0.040 236 188.35 1 0.005
15B/C 167 126.28 7 0.055 241 195.27 1 0.005
11A 167 126.28 5 0.040 242 194.23 0 0
Deidentiﬁed
group
167 126.28 26 0.206 197 158.47 3 0.019
Total 167 126.28 129 1.022 252
e 199.97 17 0.085
a The total time spent noncarrying in the study cohort.
b Acquisition was deﬁned as the onset of an episode of the serotype in question (the target serotype). For an observed transition from carriage of
one serotype (type A) to carriageof another type (type B) (72 instances altogether), the event of clearing type A was imputed midway betweenthe 2
observation times.
c The total time spent carrying some type other than the target type. For all serotypes (‘‘Total’’ line), the total time of single carriage of any of the
serotypes.
d Acquisition was deﬁned as the onset of carriage of the serotype in question in an already-carrying child. For an observed transition from
carriage of one serotype (type A) to carriage of another type (type B) (72 instances altogether), the event of clearing type A was imputed midway
between the 2 observation times.
e This is the total number of episodes of single carriage. For example, there were 220 non-6B episodes of single carriage and 32 6B episodes of
single carriage, making the total 252; likewise for any of the other serotypes.
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nation using simulated data with tripled rates of acquisition
to and from double carriage. This leaves the prevalence of
double carriage intact at the observed levelof approximately
11%, while explaining competition with both reduced ac-
quisition (h   0.3) and enhanced clearance (u   3). How-
ever, the pattern of transitions in the simulated data was
clearly different than what was observed. For example, dou-
ble carriage continued 1 month afterwards in only 1% of the
simulated data, in comparison with the 21% in the actual
observations. Consequently, even though it is possible that
enhanced acquisition occurs in double carriage, reduced
acquisition by current carriage still seems the main mecha-
nism of competition.
Another caveat in interpreting the data is that 100% sen-
sitivity in detecting double carriage was assumed. However,
a reasonably good sensitivity is indicated by the fact that
clearance of individual serotypes in double carriers was
estimated to occur at the same rate as clearance in single
carriers. If true double carriers were haphazardly classiﬁed
as single carriers of either of the carried types, clearance of
double carriage would actually be slower than detected.
Clearly, this is against the hypothesis of enhanced clearance.
Good sensitivity is also indicated by the fact that there were
relatively few children who carried the same serotype in
another episode. Only 15% of the episodes were reacquisi-
tions in the sense that there was more than 1 episode of the
serotype in question in the child.
Only a few epidemiologic studies have previously con-
sidered between-strain competition among pneumococci.
Based on follow-up of pneumococcal carriage in families,
Melegaro et al. (18) suggested that current carriage of a par-
ticular serotype reduces the rate of acquisition of other se-
rotypes. However, their model accommodated only single
carriage. Even if the rates of acquisition were equal in non-
carriers and carriers, it is then possible that between-serotype
competition would be inferred, because infrequent sampling
produces what appears as direct transitions from carriage of
one type to another. In the present paper, the model of pneu-
mococcal carriage accommodated both single carriage (only
1 colonizing serotype in an individual) and double carriage
(2 simultaneously colonizing serotypes). The results still
indicate that different serotypes compete, but the strength
of competition may have a more mechanistic interpretation
in the analysis of the present paper.
We did not consider differences across serotypes, because
the numbers of episodes of double carriage were small for
any individual serotype. However, we surmise that the gen-
eral pattern of interactions as revealed by the present anal-
ysis could at least apply to all relatively common
pneumococcal serotypes or strains. This does not exclude
the possibility of differential strain-strain interactions in
competition. The present analysis focused on simultaneous
interactions of different serotypes, as it did not address the
question of acquired immunity to subsequent acquisition or
clearance. The results thus pertain to the average pattern of
pneumococcal carriage in toddlers.
The biologic mechanism that inhibits simultaneous colo-
nization by more than 1 pneumococcal strain is incom-
pletely understood. However, a likely candidate is direct
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Am J Epidemiol 2010;171:169–176killing of one strain (competitor) by another (the resident
strain), mediated by bacteriocins, small peptides produced
by many bacterial species. In S. pneumoniae, the blp cluster
of genes determines the synthesis and secretion of several
putative bacteriocins and their corresponding immunity pro-
teins, which prevent the strain from being killed by the
bacteriocin it produced. A remarkable feature of the blp
cluster is its high genetic degree of diversity, with signs of
frequent gene rearrangements, ﬁtting the proposed role as
the material basis for interstrain competition (30, 31).
The blp cluster is under the control of a complex set of
regulatorysequencescloselyresemblingthequorum-sensing
(com) system, which triggers genetic competence in high-
density populations of pneumococci. Strain speciﬁcity is
a characteristic of both regulons, based on recognition of
a small peptide pheromone. The com system has other re-
semblances to the blp bacteriocin system: It determines sev-
eralcell-wall-degradingenzymesthatparticipateinkillingof
noncompetent pneumococci during transformation in a pro-
cesscalledfratricide. Togetherthecomandblpsystemshave
properties that could account for the competition between
pneumococcalstrains.Thecompetencesystemisclearlypart
of the regulation of genetic transformation, with the likely
function of providing for gene exchange and eventual evolu-
tion. Whether this, rather than competition between strains,
wouldbetheprimaryfunctionofthesystemremainsanopen
question (32, 33).
The extent of serotype replacement under large-scalevac-
cination depends on the strength of competition between
vaccine and nonvaccine strains. Using the model of Figure
1, Lipsitch (17) showed that when competition works
through reduced acquisition, vaccination with a vaccine tar-
geted against a speciﬁc serotype induces replacement of
carriage by the nonvaccine type. Using a similar model,
Zhang et al. (19) argued that vaccination is likely to induce
notable replacement only under competition in colonizing
hosts, whereas acquired cross-immunity may not be an im-
portant determinant of population-level effects. Zhang et al.
(19) further argued that it may not be important to identify
whether such direct competition works through reduced ac-
quisition or enhanced clearance in order to predict postvac-
cination levels of serotype-speciﬁc carriage. However, the
mechanism of replacement can be hypothesized to have
a greater impact on pneumococcal disease. Replacement
disease should be more prominent when competition and
replacement in carriage work through acquisition, because
acquisition is generally believed to pose the highest risk of
developing pneumococcal disease (34, 35).
Here we have reported new evidence for between-strain
competition among pneumococci, suggesting that the essen-
tial mechanism of competition works in acquisition rather
than in clearance of carriage. This ﬁnding was based on the
relative rarity of double (or multiple) carriage in comparison
with the point prevalence of individual serotypes in the
study population. These inferences should be reexamined
with data from other epidemiologic settings and popula-
tions. The dependence of the strength of inferred competi-
tion on the sensitivity of pneumococcus detection should
be acknowledged. Future inferences on strain competition
will greatly beneﬁt from advances in the methodology of
detecting multiple carriage.
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Table 4. Rates of Acquisition and Clearance of Streptococcus pneumoniae Carriage (Adjusted Analysis) Among
Children at 3 Day-Care Centers in Denmark, 1999–2001
Parameter
Target Serotype Deidentiﬁed Group
Estimate
a 95% CI Estimate
a 95% CI
Rate of acquisition in noncarrying children per month 0.06
b 0.04, 0.09 0.24
c 0.16, 0.33
Relative rate of acquisition in carrying children vs.
noncarrying children
0.09 0.05, 0.15 0.11 0.02, 0.31
Rate of clearance in single carriers per month 0.63 0.51, 0.79 0.63 0.41, 0.90
Relative rate of clearance in double carriers vs.
single carriers
0.81 0.48, 1.26 0.80 0.22, 2.17
Abbreviation: CI, credible interval.
a The posterior mean estimates and 95% credible intervals are given for the 2 sets of acquisition and clearance
rates (target type, deidentiﬁed group) in children, obtained by ﬁtting a longitudinal model to the data from 3 Danish
day-care centers (April 1999–February 2001).
b The analysis of the target types was adjusted for serotype-speciﬁc exposure within the day-care center, with the
mean effect of exposure (presence of the target type) on acquisition estimated at 2.7 (95% CI: 1.7, 4.4).
c The analysis of the deidentiﬁed group was not adjusted for exposure, explaining the higher rate of acquisition
than in a target serotype (0.24 acquistions per month vs. 0.06 per month).
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